Clinical trial

Added Value of Reconstructive Lymphatic Surgery to Usual Care in Lymphoedema

NCT05064176 · Universitaire Ziekenhuizen KU Leuven, Other · Recruiting

Key facts

NCT number NCT05064176
Title Added Value of Reconstructive Lymphatic Surgery to Usual Care in Lymphoedema
Official title Comparison of Reconstructive Lymphatic Surgery Versus no Surgery, Additional to Decongestive Lymphatic Therapy (Usual Care), for the Treatment of Iymphoedema, Through a Multicentre Randomised Controlled Trial
Acronym SurLym
Lead sponsor Universitaire Ziekenhuizen KU Leuven, Other
Status Recruiting
Study type Interventional
Conditions Lymphoedema of Leg, Lymphedema Arm, Lymphedema
Intervention type Other, Procedure
Interventions Usual care, Reconstructive lymphatic surgery
Enrollment 180
Start date Feb 1, 2022
Primary completion Jun 1, 2025
Completion Dec 1, 2026
First posted Oct 1, 2021
Last update posted Jul 3, 2024
Countries Belgium

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies